| GfK Healthcare | January 2010 |
GfK Healthcare Researchers Featured in MM&M's Pipeline 2010  Medical Marketing & MediaDecember 2009 What are the promising drugs of 2010? Medical Marketing & Media’s “Pipeline” looks at pharmaceutical products under development and highlights 15 with the highest approval probability and brightest commercial prospects in major categories such as cardiovascular, infectious disease, metabolic, rare disease and rheumatology. Four GfK Healthcare marketing researchers are featured in the piece providing their expert opinions on both the therapeutic classes and specific drugs covered. To download Medical Marketing & Media’s “Pipeline 2010,” click here. For more insights on these therapeutic areas from the experts included in the article, please contact the appropriate GfK Healthcare consultant listed below: Dave Jacobson Diabetes Practice Leader david.jacobson@gfk.com Mary McBride Associate Vice President, Research & Consulting mary.mcbride@gfk.com Geoff Penney Vice President/Category Business Leader geoff.penney@gfk.com Noah Pines Executive Vice President, Research & Consulting noah.pines@gfk.com |